"";"docid_page";"row";"col";"value";"characteristic_level";"characteristic_name";"arms"
"1";"10789664_1";6;4;"31.9";"Black non-Hispanic";"Race/ethnicity, % White non-Hispanic";"Chlorthalidone Group"
"2";"10789664_1";6;5;"32.9";"Black non-Hispanic";"Race/ethnicity, % White non-Hispanic";"Doxazosin Group"
"3";"10789664_1";7;4;"12.6";"White Hispanic";"Race/ethnicity, % White non-Hispanic";"Chlorthalidone Group"
"4";"10789664_1";7;5;"12.6";"White Hispanic";"Race/ethnicity, % White non-Hispanic";"Doxazosin Group"
"5";"10789664_1";8;4;"3.3";"Black Hispanic";"Race/ethnicity, % White non-Hispanic";"Chlorthalidone Group"
"6";"10789664_1";8;5;"3.4";"Black Hispanic";"Race/ethnicity, % White non-Hispanic";"Doxazosin Group"
"7";"10789664_1";9;4;"5.1";"Other race";"Race/ethnicity, % White non-Hispanic";"Chlorthalidone Group"
"8";"10789664_1";9;5;"4.6";"Other race";"Race/ethnicity, % White non-Hispanic";"Doxazosin Group"
"9";"10789664_1";5;4;"47.2";NA;"Race/ethnicity, % White non-Hispanic";"Chlorthalidone Group"
"10";"10789664_1";5;5;"46.4";NA;"Race/ethnicity, % White non-Hispanic";"Doxazosin Group"
"11";"10789664_1";10;4;"11 (4)";"Other race";"Education, y";"Chlorthalidone Group"
"12";"10789664_1";10;5;"11 (4)";"Other race";"Education, y";"Doxazosin Group"
"13";"10789664_1";11;4;"145/83(14/10)";"Other race";"Blood pressure, mm Hg";"Chlorthalidone Group"
"14";"10789664_1";11;5;"145/84(14/10)";"Other race";"Blood pressure, mm Hg";"Doxazosin Group"
"15";"10789664_1";12;4;"90.2";"Other race";"Treated for hypertension, %";"Chlorthalidone Group"
"16";"10789664_1";12;5;"90.3";"Other race";"Treated for hypertension, %";"Doxazosin Group"
"17";"10789664_1";13;4;"45.2";"Other race";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"18";"10789664_1";13;5;"45.6";"Other race";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"19";"10789664_1";14;4;"10.1";"ST-T wave changes";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"20";"10789664_1";14;5;"9.8";"ST-T wave changes";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"21";"10789664_1";15;4;"35.9";"Type 2 diabetes";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"22";"10789664_1";15;5;"35.1";"Type 2 diabetes";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"23";"10789664_1";16;4;"21.9";"Cigarette smoking";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"24";"10789664_1";16;5;"21.7";"Cigarette smoking";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"25";"10789664_1";17;4;"12.3";"HDL-C <35 mg/dL";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"26";"10789664_1";17;5;"12.0";"HDL-C <35 mg/dL";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"27";"10789664_1";18;4;"15.8";"LVH (from electrocardiogram)";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"28";"10789664_1";18;5;"16.0";"LVH (from electrocardiogram)";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"29";"10789664_1";19;4;"4.2";"LVH (from echocardiogram)";"Eligibility risk factors, %t ASCVO";"Chlorthalidone Group"
"30";"10789664_1";19;5;"4.2";"LVH (from echocardiogram)";"Eligibility risk factors, %t ASCVO";"Doxazosin Group"
"31";"10789664_1";20;4;"4.3 (0.7)";"LVH (from echocardiogram)";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"32";"10789664_1";20;5;"4.4 (0.7)";"LVH (from echocardiogram)";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"33";"10789664_1";21;4;"124(58)";"Fasting glucose, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"34";"10789664_1";21;5;"123(56)";"Fasting glucose, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"35";"10789664_1";22;4;"1.0 (0.3)";"Creatinine, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"36";"10789664_1";22;5;"1.0 (0.3)";"Creatinine, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"37";"10789664_1";23;4;"216(44)";"Cholesterol, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"38";"10789664_1";23;5;"215(42)";"Cholesterol, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"39";"10789664_1";24;4;"136(37)";"LDL-C, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"40";"10789664_1";24;5;"135(36)";"LDL-C, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"41";"10789664_1";25;4;"47 (15)";"HDL-C, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"42";"10789664_1";25;5;"47 (14)";"HDL-C, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"43";"10789664_1";26;4;"173(131)";"Fasting triglycerides, mg/dL";"Serum biochemistry Potassium, mmol/L";"Chlorthalidone Group"
"44";"10789664_1";26;5;"170(135)";"Fasting triglycerides, mg/dL";"Serum biochemistry Potassium, mmol/L";"Doxazosin Group"
"45";"10789664_1";2;4;"15268";NA;"No. of subjects";"Chlorthalidone Group"
"46";"10789664_1";2;5;"9067";NA;"No. of subjects";"Doxazosin Group"
"47";"10789664_1";3;4;"67(8)";NA;"Age, y";"Chlorthalidone Group"
"48";"10789664_1";3;5;"67(8)";NA;"Age, y";"Doxazosin Group"
"49";"10789664_1";4;4;"47.0";NA;"Women, %";"Chlorthalidone Group"
"50";"10789664_1";4;5;"46.4";NA;"Women, %";"Doxazosin Group"
